Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/19769 |
Resumo: | Although self-medication is a common practice, it can lead to several health problems, such as masking diseases, causing drug interactions, bacterial resistance and intoxication. During the COVID-19 pandemic many news articles were spread encouraging the use of drugs for the prevention and treatment of SARS-CoV-2, such as chloroquine, hydroxychloroquine, nitazoxanide, ivermectin, etc. However, there is no scientific proof of their efficacy for this purpose. The objective of the present study was to systematically review the existing literature on self-medication and relate it to the COVID-19 pandemic. A literature review search was performed and a total of 27 scientific articles were summarized and discussed. Self-medication as a result of panic, bad information, and the culture that Brazilians have of self-diagnosing have collaborated to the increase of these practices. Misinformation in the social networks about pharmacological treatments favored the shortage of pharmacies and drugstores, harming even hospital care. Drugs advertised as prophylactic and curative for the new coronavirus proved to be ineffective in vivo clinical trials applied mostly in hospitalized patients with COVID-19, except for remdesivir and dexamethasone, which contributed significantly in the treatment of moderate to severe cases. Pharmaceutical professionals were important in raising public awareness about the adverse effects of drugs, fighting fake news, and producing vaccines. It was also possible to observe the lack of resources that Brazilian universities have to generate science, making financial support necessary to enable research into new drugs and vaccine manufacturing. |
id |
UNIFEI_9b884a719f3bf803b1aa450a91ae5067 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/19769 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic reviewLa automedicación en Brasil durante la pandemia de COVID-19 y el papel del profesional farmacéutico, una revisión sistemáticaAutomedicação no Brasil durante a pandemia da COVID-19 e o papel do profissional farmacêutico, uma revisão sistemáticaAutomedicaçãoFatores de riscosPandemia da COVID-19Farmacêuticos.La automedicaciónFactores de riesgoPandemia COVID-19Los farmacéuticos. Self-medicationRisk factorsCOVID-19 pandemicPharmacists.Although self-medication is a common practice, it can lead to several health problems, such as masking diseases, causing drug interactions, bacterial resistance and intoxication. During the COVID-19 pandemic many news articles were spread encouraging the use of drugs for the prevention and treatment of SARS-CoV-2, such as chloroquine, hydroxychloroquine, nitazoxanide, ivermectin, etc. However, there is no scientific proof of their efficacy for this purpose. The objective of the present study was to systematically review the existing literature on self-medication and relate it to the COVID-19 pandemic. A literature review search was performed and a total of 27 scientific articles were summarized and discussed. Self-medication as a result of panic, bad information, and the culture that Brazilians have of self-diagnosing have collaborated to the increase of these practices. Misinformation in the social networks about pharmacological treatments favored the shortage of pharmacies and drugstores, harming even hospital care. Drugs advertised as prophylactic and curative for the new coronavirus proved to be ineffective in vivo clinical trials applied mostly in hospitalized patients with COVID-19, except for remdesivir and dexamethasone, which contributed significantly in the treatment of moderate to severe cases. Pharmaceutical professionals were important in raising public awareness about the adverse effects of drugs, fighting fake news, and producing vaccines. It was also possible to observe the lack of resources that Brazilian universities have to generate science, making financial support necessary to enable research into new drugs and vaccine manufacturing.Aunque la automedicación es una práctica habitual, puede dar lugar a varios trastornos de la salud, como enmascarar enfermedades, provocar interacciones farmacológicas, resistencia bacteriana e intoxicación. Durante la pandemia de COVID-19 se difundieron muchas noticias que alentaban el uso de medicamentos para la prevención y el tratamiento del SARS-CoV-2, como la cloroquina, la hidroxicloroquina, la nitazoxanida, la ivermectina, etc. Sin embargo, no hay pruebas científicas de su eficacia para este fin. El objetivo del presente estudio fue revisar la literatura existente sobre la automedicación y relacionarla con la pandemia de COVID-19. Se realizó una búsqueda bibliográfica sistemática y se resumieron y discutieron un total de 27 artículos científicos. La automedicación como resultado del pánico, la mala información y la cultura que tienen los brasileños de autodiagnosticarse colaboraron al aumento de estas prácticas. Las divulgaciones incorrectas en las redes sociales sobre los tratamientos farmacológicos favorecieron la escasez de farmacias y droguerías, perjudicando incluso la atención hospitalaria. Los fármacos anunciados como profilácticos y curativos del nuevo coronavirus resultaron ineficaces en los ensayos clínicos in vivo aplicados sobre todo en pacientes hospitalizados con COVID-19, excepto el remdesivir y la dexametasona que contribuyeron significativamente en el tratamiento de los casos moderados a graves. Los profesionales farmacéuticos demostraron ser importantes para la concienciación de la población sobre los efectos adversos de los medicamentos, la lucha contra las noticias falsas y la producción de vacunas. También se pudo observar la falta de recursos que tienen las universidades brasileñas para generar ciencia, haciendo necesario el apoyo financiero para permitir la investigación de nuevos medicamentos y la fabricación de vacunas.mascarar doenças, provocar interações medicamentosas, resistência bacteriana e intoxicação. Durante a pandemia da COVID-19 muitas notícias foram propagadas estimulando o uso de medicamentos para a prevenção e tratamento do SARS-CoV-2, como a cloroquina, hidroxicloroquina, nitazoxanida, ivermectina, etc. Todavia, não há comprovação científica sobre a eficácia dos mesmos para essa finalidade. O objetivo do presente estudo foi revisar a literatura existente sobre automedicação e relacioná-la à pandemia da COVID-19. Foi realizada pesquisa bibliográfica sistemática e um total de 27 artigos científicos foram sumarizados e discutidos. A automedicação em decorrência do pânico, más informações e da cultura que os brasileiros têm de se autodiagnosticar colaboraram para o aumento dessas práticas. Divulgações equivocadas nas redes sociais sobre tratamentos farmacológicos favoreceram o desabastecimento de farmácias e drogarias, prejudicando até mesmo atendimentos hospitalares. Medicamentos divulgados como profiláticos e curativos do novo coronavírus se mostraram ineficazes em pesquisas clínicas in vivo aplicadas em sua maioria em pacientes hospitalizados com COVID-19, exceto o remdesivir e a dexametasona que contribuíram de forma significativa nos tratamentos de casos moderados a graves. Profissionais farmacêuticos se mostraram importantes para a conscientização da população sobre os efeitos adversos dos fármacos, combate a fake news e produção de vacinas. Também foi possível observar a falta de recursos que as universidades brasileiras têm para gerar ciência, fazendo-se necessário apoio financeiro para possibilitar pesquisas de novos fármacos e fabricação de vacinas.Research, Society and Development2021-09-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1976910.33448/rsd-v10i11.19769Research, Society and Development; Vol. 10 No. 11; e496101119769Research, Society and Development; Vol. 10 Núm. 11; e496101119769Research, Society and Development; v. 10 n. 11; e4961011197692525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/19769/17764Copyright (c) 2021 Larissa Aparecida dos Santos Martins Oliveira; Andreza Martins de Souza; Vanessa Medeiros Custódio; Juliana Souza Dionísio dos Santos; Luana dos Santos Castro; Daniel Teles Zatta; Rodrigo Luís Taminato; Fernando Yano Abrãohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessOliveira, Larissa Aparecida dos Santos MartinsSouza, Andreza Martins deCustódio, Vanessa MedeirosSantos, Juliana Souza Dionísio dosCastro, Luana dos SantosZatta, Daniel TelesTaminato, Rodrigo LuísAbrão, Fernando Yano2021-10-23T19:01:11Zoai:ojs.pkp.sfu.ca:article/19769Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:39:36.246047Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review La automedicación en Brasil durante la pandemia de COVID-19 y el papel del profesional farmacéutico, una revisión sistemática Automedicação no Brasil durante a pandemia da COVID-19 e o papel do profissional farmacêutico, uma revisão sistemática |
title |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review |
spellingShingle |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review Oliveira, Larissa Aparecida dos Santos Martins Automedicação Fatores de riscos Pandemia da COVID-19 Farmacêuticos. La automedicación Factores de riesgo Pandemia COVID-19 Los farmacéuticos. Self-medication Risk factors COVID-19 pandemic Pharmacists. |
title_short |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review |
title_full |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review |
title_fullStr |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review |
title_full_unstemmed |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review |
title_sort |
Self-medication in Brazil during the pandemic of COVID-19 and the role of the pharmaceutical professional, a systematic review |
author |
Oliveira, Larissa Aparecida dos Santos Martins |
author_facet |
Oliveira, Larissa Aparecida dos Santos Martins Souza, Andreza Martins de Custódio, Vanessa Medeiros Santos, Juliana Souza Dionísio dos Castro, Luana dos Santos Zatta, Daniel Teles Taminato, Rodrigo Luís Abrão, Fernando Yano |
author_role |
author |
author2 |
Souza, Andreza Martins de Custódio, Vanessa Medeiros Santos, Juliana Souza Dionísio dos Castro, Luana dos Santos Zatta, Daniel Teles Taminato, Rodrigo Luís Abrão, Fernando Yano |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Oliveira, Larissa Aparecida dos Santos Martins Souza, Andreza Martins de Custódio, Vanessa Medeiros Santos, Juliana Souza Dionísio dos Castro, Luana dos Santos Zatta, Daniel Teles Taminato, Rodrigo Luís Abrão, Fernando Yano |
dc.subject.por.fl_str_mv |
Automedicação Fatores de riscos Pandemia da COVID-19 Farmacêuticos. La automedicación Factores de riesgo Pandemia COVID-19 Los farmacéuticos. Self-medication Risk factors COVID-19 pandemic Pharmacists. |
topic |
Automedicação Fatores de riscos Pandemia da COVID-19 Farmacêuticos. La automedicación Factores de riesgo Pandemia COVID-19 Los farmacéuticos. Self-medication Risk factors COVID-19 pandemic Pharmacists. |
description |
Although self-medication is a common practice, it can lead to several health problems, such as masking diseases, causing drug interactions, bacterial resistance and intoxication. During the COVID-19 pandemic many news articles were spread encouraging the use of drugs for the prevention and treatment of SARS-CoV-2, such as chloroquine, hydroxychloroquine, nitazoxanide, ivermectin, etc. However, there is no scientific proof of their efficacy for this purpose. The objective of the present study was to systematically review the existing literature on self-medication and relate it to the COVID-19 pandemic. A literature review search was performed and a total of 27 scientific articles were summarized and discussed. Self-medication as a result of panic, bad information, and the culture that Brazilians have of self-diagnosing have collaborated to the increase of these practices. Misinformation in the social networks about pharmacological treatments favored the shortage of pharmacies and drugstores, harming even hospital care. Drugs advertised as prophylactic and curative for the new coronavirus proved to be ineffective in vivo clinical trials applied mostly in hospitalized patients with COVID-19, except for remdesivir and dexamethasone, which contributed significantly in the treatment of moderate to severe cases. Pharmaceutical professionals were important in raising public awareness about the adverse effects of drugs, fighting fake news, and producing vaccines. It was also possible to observe the lack of resources that Brazilian universities have to generate science, making financial support necessary to enable research into new drugs and vaccine manufacturing. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-07 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19769 10.33448/rsd-v10i11.19769 |
url |
https://rsdjournal.org/index.php/rsd/article/view/19769 |
identifier_str_mv |
10.33448/rsd-v10i11.19769 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/19769/17764 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 11; e496101119769 Research, Society and Development; Vol. 10 Núm. 11; e496101119769 Research, Society and Development; v. 10 n. 11; e496101119769 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052688348741632 |